Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
42 hedge funds and large institutions have $81.6M invested in Flexion Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 8 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 9
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
5% more funds holding
Funds holding: 40 → 42 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less capital invested
Capital invested by funds: $108M → $81.6M (-$26.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
+$2.9M |
| 2 |
KCM
Kingdon Capital Management
New York
|
+$1.55M |
| 3 |
Jennison Associates
New York
|
+$1.24M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$383K |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$379K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$7.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.81M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.23M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.71M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$823K |
FLXN Hedge Fund Activity: Q2 2014 in Review
42 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q2 2014, worth a combined $81.6M — down 25% from $108M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new FLXN positions and 8 closed out — a net gain of 2 holders — while 18 added to existing stakes and 9 trimmed.
The largest buyer was Visium Asset Management, adding an estimated $2.9M. The largest seller was RA Capital Management, exiting entirely with an estimated $7.4M sold.
- 42 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q2 2014, up from 40 in Q1 2014.
- Funds reported $81.6M of Flexion Therapeutics, Inc. stock for Q2 2014, down 25% quarter-over-quarter.
- 10 funds opened new Flexion Therapeutics, Inc. positions in Q2 2014 and 8 closed out, a net change of +2 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q2 2014 was Visium Asset Management, an estimated $2.9M added.
- The largest Flexion Therapeutics, Inc. seller in Q2 2014 was RA Capital Management, an estimated $7.4M sold.
Based on aggregated 13F filings for Q2 2014.